Registered Malawi · PMRA

GARDASIL RECOMBINANT VACCINE INJECTION

QUADRIVALENT HUM.PAPILLOMAVIRUS 6,11,16,18

PMPB/PL28/27 INJECTION

What it does

Quadrivalent vaccines help protect against four different strains of a virus, typically used to prevent certain diseases.

Commonly used for: prevention of influenza (flu), prevention of certain types of pneumonia

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
PMPB/PL28/27
Registration date
22/08/2007
Expiry date
31/03/2025
Status
Registered
Active ingredient
QUADRIVALENT HUM.PAPILLOMAVIRUS 6,11,16,18
Dosage form
INJECTION
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
-
Applicant / LTR
-
Country of origin
-

Source: Pharmacy and Medicines Regulatory Authority · fetched 2026-04-21 17:37:38 · updated 2026-09-19 04:30:21

Disclaimer: This information is sourced from Pharmacy and Medicines Regulatory Authority (Malawi). Always consult a qualified healthcare professional before using any medication.

About this medicine

Quadrivalent vaccines help protect against four different strains of a virus, typically used to prevent certain diseases.

What it treats

  • prevention of influenza (flu)
  • prevention of certain types of pneumonia

How it works

These vaccines stimulate the body's immune system to recognize and fight off specific viruses.

Who it's for

This vaccine is for individuals who need protection against multiple strains of the virus, including children and adults.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: quadrivalent

Quadrivalent vaccines are designed to protect against four different strains of a virus, commonly referring to the quadrivalent influenza vaccine which targets two influenza A strains and two influenza B strains. This type of vaccine is crucial in preventing seasonal influenza outbreaks and is especially important for high-risk populations.

Indications

  • Prevention of influenza in adults and children
  • Protection for high-risk groups, including the elderly and those with chronic health conditions
  • Seasonal influenza vaccination campaigns

Dosage

Children: Refer to specific vaccination guidelines for children, with recommendations depending on age and previous vaccination history.

Adults: Refer to specific vaccination guidelines for adults, typically administered as a single dose per season.

Mechanism of action

Quadrivalent vaccines work by introducing inactivated or attenuated virus strains into the body, which stimulates the immune system to produce antibodies. These antibodies recognize and neutralize the virus upon subsequent exposure, thereby providing immunity against the targeted strains.

Pharmacodynamics

The pharmacodynamics of quadrivalent vaccines involve the activation of the adaptive immune response, leading to the production of specific antibodies against the influenza virus. This response typically peaks 2 to 4 weeks after vaccination, providing protective immunity. Vaccination not only reduces the risk of infection but also mitigates the severity of the disease in vaccinated individuals.

Pharmacokinetics

Quadrivalent vaccines are administered via intramuscular injection, leading to rapid absorption into the systemic circulation. The half-life of the immune response varies based on individual factors but generally provides immunity for several months. The vaccine components are processed by the immune system, with antibodies being produced and maintained in memory B cells for long-term protection.

Adverse effects

  • Injection site reactions
  • Fever
  • Headache
  • Fatigue
  • Nausea
  • Myalgia

Precautions

  • Use with caution in individuals with a history of allergic reactions to vaccine components
  • Monitor for any severe allergic reactions post-vaccination
  • Consider underlying health conditions that may affect immune response

Pregnancy

Quadrivalent vaccines can be administered during pregnancy if the benefits outweigh the risks, especially during outbreaks or high-risk situations.

Breast-feeding

Safe to administer during breastfeeding.

Storage

Store in the refrigerator at 2°C to 8°C. Do not freeze. Protect from light.

Formulations

  • Quadrivalent inactivated influenza vaccine
  • Quadrivalent human papillomavirus vaccine

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.